Early trial tests new pill for psoriasis skin symptoms
NCT ID NCT05453942
Summary
This early-stage study tested a 4-week oral treatment called SAR441566 for people with mild to moderate psoriasis. The main goal was to check the treatment's safety and how well it was tolerated. Researchers also measured if it reduced the severity of skin lesions compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :2760001
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.